JP2005528124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528124A5 JP2005528124A5 JP2004510698A JP2004510698A JP2005528124A5 JP 2005528124 A5 JP2005528124 A5 JP 2005528124A5 JP 2004510698 A JP2004510698 A JP 2004510698A JP 2004510698 A JP2004510698 A JP 2004510698A JP 2005528124 A5 JP2005528124 A5 JP 2005528124A5
- Authority
- JP
- Japan
- Prior art keywords
- anv
- seq
- genetically modified
- protein
- dna molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000672 Annexin A5 Proteins 0.000 claims 6
- 102000004121 Annexin A5 Human genes 0.000 claims 6
- 102000053602 DNA Human genes 0.000 claims 4
- 239000002506 anticoagulant protein Substances 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 108020004414 DNA Proteins 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108700019335 ANV-6L15 Proteins 0.000 claims 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 2
- 102100030951 Tissue factor pathway inhibitor Human genes 0.000 claims 2
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 230000004927 fusion Effects 0.000 claims 2
- 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 238000003259 recombinant expression Methods 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 108020004511 Recombinant DNA Proteins 0.000 claims 1
- 230000002785 anti-thrombosis Effects 0.000 claims 1
- 229940127219 anticoagulant drug Drugs 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000023555 blood coagulation Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000001732 thrombotic effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38693202P | 2002-06-06 | 2002-06-06 | |
| PCT/US2003/017442 WO2003103577A2 (en) | 2002-06-06 | 2003-06-04 | Novel recombinant anticoagulant proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005528124A JP2005528124A (ja) | 2005-09-22 |
| JP2005528124A5 true JP2005528124A5 (enExample) | 2006-07-20 |
| JP4444821B2 JP4444821B2 (ja) | 2010-03-31 |
Family
ID=29736237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004510698A Expired - Fee Related JP4444821B2 (ja) | 2002-06-06 | 2003-06-04 | 遺伝子組み換えによる新しい抗凝血性蛋白質 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7378393B2 (enExample) |
| EP (1) | EP1509541B1 (enExample) |
| JP (1) | JP4444821B2 (enExample) |
| CN (1) | CN1659180B (enExample) |
| AT (1) | ATE534658T1 (enExample) |
| AU (1) | AU2003237351B2 (enExample) |
| CA (1) | CA2486362A1 (enExample) |
| WO (1) | WO2003103577A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7635680B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaceuticals, Inc. | Attenuation of reperfusion injury |
| US7635676B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaccuticals, Inc. | Modified annexin proteins and methods for their use in organ transplantation |
| US7671013B2 (en) * | 2003-04-03 | 2010-03-02 | Canadian Blood Services, Inc. | Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses |
| CA2559167A1 (en) * | 2004-03-11 | 2005-09-22 | Alavita, Inc. | Modified annexin proteins and methods for preventing thrombosis |
| US7511016B2 (en) * | 2004-07-07 | 2009-03-31 | Mosamedix B.V. | Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| PL2234631T3 (pl) | 2007-12-18 | 2013-03-29 | Athera Biotechnologies Ab | Związki i metody stosowane w terapii choroby naczyniowej |
| HUE044621T2 (hu) * | 2008-02-22 | 2019-11-28 | Annexin Pharmaceuticals Ab | Vegyületek és eljárások resztenózis megelõzésére vagy kezelésére |
| CA2740557C (en) | 2008-10-17 | 2020-04-14 | London Health Sciences Centre Research Inc. | Annexin and its use to treat inflammatory disorders |
| JP6200806B2 (ja) | 2010-05-21 | 2017-09-20 | メリマック ファーマシューティカルズ インコーポレーティッド | 二重特異的融合タンパク質 |
| CN115960249A (zh) | 2015-10-02 | 2023-04-14 | 银溪制药股份有限公司 | 用于组织修复的双特异性治疗性蛋白质 |
| BR102017005783A2 (pt) * | 2017-03-21 | 2018-10-02 | Fund Butantan | processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos |
| TW202146042A (zh) * | 2020-03-06 | 2021-12-16 | 瑞典商阿斯特捷利康公司 | 用於治療動脈和靜脈血栓形成的協同且靶向的組成物 |
| CN113956339B (zh) * | 2021-10-28 | 2023-02-24 | 中国药科大学 | 宽体金线蛭抗凝血因子XIa多肽及其应用 |
| CN116444640A (zh) * | 2022-09-26 | 2023-07-18 | 昆明医科大学 | 一种版纳绳蚋抗栓肽Sibanin及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0412155A4 (en) | 1987-03-27 | 1991-04-03 | Terumo Kabushiki Kaisha | Enzyme sensor |
| EP0965597A4 (en) | 1996-12-27 | 2003-01-08 | Mochida Pharm Co Ltd | CELL MEMBRANE EFFECTIVE DRUGS |
-
2003
- 2003-06-04 JP JP2004510698A patent/JP4444821B2/ja not_active Expired - Fee Related
- 2003-06-04 AT AT03736814T patent/ATE534658T1/de active
- 2003-06-04 US US10/516,908 patent/US7378393B2/en not_active Expired - Lifetime
- 2003-06-04 CN CN03812999XA patent/CN1659180B/zh not_active Expired - Fee Related
- 2003-06-04 CA CA002486362A patent/CA2486362A1/en not_active Abandoned
- 2003-06-04 AU AU2003237351A patent/AU2003237351B2/en not_active Ceased
- 2003-06-04 WO PCT/US2003/017442 patent/WO2003103577A2/en not_active Ceased
- 2003-06-04 EP EP03736814A patent/EP1509541B1/en not_active Expired - Lifetime
-
2008
- 2008-04-11 US US12/101,343 patent/US20090029444A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005528124A5 (enExample) | ||
| TW494138B (en) | Methods of producing hydrophobic polypeptides in E coli | |
| WO1988005053A1 (fr) | Peptide servant a accelerer l'activation de la proteine c avec de la thrombine | |
| CN102154253A (zh) | 具有抑制血小板凝集功能的微小纤溶酶原突变体及其制备方法和用途 | |
| KR20160067219A (ko) | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 | |
| CA2374675A1 (en) | Modified factor viii | |
| JP2005538932A5 (enExample) | ||
| CA2443617A1 (en) | Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions | |
| JP2005523681A5 (enExample) | ||
| WO2014180288A1 (zh) | 具有抑制肿瘤微环境血管再生和激活适应性免疫应答双功能的融合蛋白及其基因和应用 | |
| SK26493A3 (en) | Aprotinin analogues | |
| JP2005519617A5 (enExample) | ||
| WO2005118627A3 (en) | Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use | |
| CA2011008C (en) | Egf variants and pharmaceutical use thereof | |
| CN101302255B (zh) | 基质金属蛋白酶导向性重组人肿瘤坏死因子融合蛋白及制备 | |
| JP4592756B2 (ja) | 高分子形マンノース結合型レクチンの大量生産方法 | |
| JP2004532037A5 (enExample) | ||
| JPH04505554A (ja) | 可溶性トロンボモジュリン類似体 | |
| JP2002502611A5 (enExample) | ||
| AU663216B2 (en) | Bone-related cadherin-like protein and process for its production | |
| JP2004527239A5 (enExample) | ||
| Østerud et al. | Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions | |
| WO1999055864A1 (fr) | Nouveau polypeptide, adnc le codant et son utilisation | |
| Wang et al. | The cloning and expression of renalase and the preparation of its monoclonal antibody | |
| JPS6034915A (ja) | ポリペプチド |